October 14, 2016
IntegraGen Reports Loss for First Half of 2016
The net result over the first six months of 2016 was a loss of €1,028K compared to a loss of €872K in H1 2015.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
October 13, 2016
Horizon Pharma offers $300M senior notes and borrows money for buying Raptor Pharmaceuticals
Horizon Pharma, with its wholly owned subsidiaries, Horizon Pharma, Inc. and Horizon Pharma USA, Inc., intends to offer $300 million aggregate principal amount of senior notes due 2024, and to borrow $375 million.
October 13, 2016
Theradiag: Revenue growth at end September 2016 +31%
THERADIAG a company specializing in in vitro diagnostics and theranostics, has reported its consolidated revenues for the 3rd quarter of 2016.
October 13, 2016
STENTYS sees revenue up 26%over the first 9 months
STENTYS a medical technology company today announced its revenue for the third quarter and first 9 months to September 30, 2016.
September 28, 2016
Pfizer decides against split-up; more deals seen likely
Pfizer, which was considering splitting itself for more than two years, said on Monday it would not do so, prompting shareholders to expect more deals that could bolster its roster of new medicines.
September 12, 2016
Horizon buys Raptor for $800M
Horizon Pharma and Raptor Pharmaceutical Corp.have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued…
September 12, 2016
New Board member to Verona Pharma
Verona Pharma #VRP appoints Vikas Sinha to the Board as a Non-Executive Director
July 29, 2016
Sanofi reports net income €1,158m, down 11.1%
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
July 25, 2016
Faron and Abzena in cancer medicine Clevegen manufacture deal
Faron and Abzena in cancer medicine Clevegen manufacture deal
July 8, 2016
PureTech Health introduces new members to its Scientific Advisory Board
PureTech Health has introduced new members to its Scientific Advisory Board